Wirth Peter is a director of Zai Lab Limited.
Person profile
Roles
Zai Lab Limited
Director
Syros Pharmaceuticals
Director
Address
Boston, Massachusetts
Employees
Incorporated
Fiscal year end
Industry (SIC)
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zai Lab Ltd
30 Jun 23
4
Syros Pharmaceuticals, Inc.
2 Jun 23
4/A
Zai Lab Ltd
12 Dec 22
4
Zai Lab Ltd
9 Dec 22
4
Forma Therapeutics Holdings, Inc.
14 Oct 22
4
Syros Pharmaceuticals, Inc.
19 Sep 22
4
Forma Therapeutics Holdings, Inc.
9 Jun 22
4
Syros Pharmaceuticals, Inc.
2 Jun 22
4
Zai Lab Ltd
4 Jan 22
4
Zai Lab Ltd
8 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jun 23 | ZLAB Zai Lab Limited | American Depositary Shares | Grant | Acquire A | No | No | 26.45 | 18,903 | 499.98 k | 361,666 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 4,000 | 0.00 | 12,000 |
1 Jun 23 | SYRS Syros Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.7 | 6,000 | 22.20 k | 6,000 |
8 Dec 22 | ZLAB Zai Lab Limited | American Depositary Shares | Sell | Dispose S | Yes | No | 35.33 | 4,000 | 141.32 k | 0 |
8 Dec 22 | ZLAB Zai Lab Limited | American Depositary Shares | Sell | Dispose S | No | No | 35.37 | 3,852 | 136.25 k | 342,763 |